In vivo efficacy studies of novel quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors, in lung cancer xenografts (NCI-H1975) mice models
Debasis Das, Lingzhi Xie, Jingbing Wang, Jingli Shi, Jian Hong
Topics & Concepts
T790MAfatinibOsimertinibIn vivoChemistryQuinazolineLung cancerEGFR inhibitorsPharmacologyCancer researchCancerLapatinibAdenocarcinomaBiochemistryEpidermal growth factor receptorMedicineErlotinibBreast cancerStereochemistryBiologyGefitinibOncologyInternal medicineReceptorBiotechnologyTrastuzumabLung Cancer Treatments and MutationsQuinazolinone synthesis and applicationsCancer therapeutics and mechanisms